[12 years of Melphalan therapy in a case of Igu-lambda plasmacytoma and resulting therapeutic suggestions].
D006801:Humans; D007147:Immunoglobulin Light Chains; D007146:Immunoglobulin lambda-Chains; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use*; D008722:Methods; D008875:Middle Aged; D009277:Nandrolone / Q000008:administration & dosage / Q000627:therapeutic use; D010954:Plasmacytoma / Q000188:drug therapy* / Q000276:immunology
D007147:Immunoglobulin Light Chains; D007146:Immunoglobulin lambda-Chains; D009277:Nandrolone; D008558:Melphalan
Dwunastoletni okres leczenia melfalanem przypadku siatkowiaka plazmocytowego Igu-lambda i wynikajace stad sugestie terapeutyczne